DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



The Use of Antibiotic Sinonasal Rinse After Sinus Surgery

Information source: University of Miami
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Chronic Rhinosinusitis

Intervention: Mupirocin (Drug); Placebo (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: University of Miami

Summary

Double blind placebo controlled trial to evaluate whether the routine use of nasal irrigation with mupirocin is more effective than saline irrigations alone in reducing symptoms of chronic rhinosinusitis in the early postoperative period.

Clinical Details

Official title: The Use of Antibiotic Sinonasal Rinse After Sinus Surgery: A Randomized Double-Blind Control Trial

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Primary outcome: Quality of Life in Chronic Rhinosinusitis Patients

Secondary outcome: Quality of Life in Chronic Rhinosinusitis Patients

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Chronic Rhinosinusitis

- Undergoing endoscopic sinus surgery

Exclusion Criteria:

- Age under 18

- Documented adverse reaction to mupirocin

Locations and Contacts

University of Miami Miller School of Medicine, ENT Dept, Miami, Florida 33136, United States
Additional Information

Starting date: November 2011
Last updated: July 6, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017